408 results on '"Shankavaram, Uma"'
Search Results
2. De novo TLK1 and MDM1 mutations in a patient with a neurodevelopmental disorder and immunodeficiency
3. Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer
4. Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis
5. Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis
6. Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey
7. Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer
8. Serum RNA biomarkers for predicting survival in non-human primates following thoracic radiation
9. Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation
10. Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
11. A long noncoding RNA–microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas
12. Figure S6 from Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention
13. Table S1 from Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention
14. Data from Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention
15. Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
16. Molecular landscape of FaDu xenograft tumors in mice after a combinatorial treatment with radiation and an HSP90 inhibitor identifies adaptation-induced targets
17. Comparison of Proteomic Biodosimetry Biomarkers Across Five Different Murine Strains
18. Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures
19. Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
20. Proteomic Biomarker Analysis of Serum from Japanese Field Mice (Apodemus Speciosus) Collected within the Fukushima Difficult-to-return Zone
21. Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation
22. Multivariate Analysis of Radiation Responsive Proteins to Predict Radiation Exposure in Total-Body Irradiation and Partial-Body Irradiation Models
23. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
24. Identification of ade novomutation inTLK1associated with a neurodevelopmental disorder and immunodeficiency
25. Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
26. Comparative Analysis of miRNA Expression after Whole-Body Irradiation Across Three Strains of Mice
27. Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a largescale proteomic panel.
28. Preclinical Models of Glioblastoma in Radiobiology: Evolving Protocols and Research Methods
29. Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
30. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster
31. Supplementary Figure from Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity
32. Supplementary Figure 5 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
33. Supplementary Figure 2 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
34. Supplementary Figure 1 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
35. Supplementary Figure 6 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
36. Supplementary Figure 4 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
37. Data from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
38. Supplementary Figure 3 from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
39. Data from Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity
40. Supplementary Data from Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity
41. Supplementary methods from Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins
42. Supplementary Table 2 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells
43. Figure S1 from Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem–like Cells
44. Supplementary Table 1 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells
45. Data from Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem–like Cells
46. Supplementary Table 3 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells
47. Supplementary Table 1 from Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses
48. Data from Translation Initiation Factor eIF4E Is a Target for Tumor Cell Radiosensitization
49. Supplementary Data from Membrane Transporters and Channels
50. Data from Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.